OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells. - Wikidata - awgldk - TriplyDB

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

http://www.wikidata.org/entity/Q35122057

about

Protein interaction network of alternatively spliced NudCD1 isoforms.Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.

P2860

Q42374877-9BD65DD5-263F-4729-B4B6-B50AFC3F877D Q54254509-ABAFF937-6252-4D18-AB75-74E6981DB33C Q55013675-43AD1971-2117-4A7E-BC98-EE59FA39A14F

P2860

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

http://www.wikidata.org/entity/Q35122057

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@ast

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@en

type

label

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@ast

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@en

prefLabel

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@ast

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@en

P1433

Q35122057-DF1CE63B-3BA4-4CF5-A351-CAEC743C3009

P1476

Q35122057-B2693AE0-F5F8-4D87-9194-49E960E3D90D

P2093

Q35122057-2C063FC1-8BE4-4008-8643-47BF4F1CBBF6

Q35122057-3B227B3F-21E5-4EBC-864A-1B2339CB1541

Q35122057-88C85EAF-B1ED-4398-B4EE-FF209D342C16

Q35122057-8CFD7A2D-8216-43BE-A54C-FA8F91A58711

Q35122057-8D80C3D8-ADF5-4011-82F6-6EF7379F76C7

Q35122057-9B9E2FB6-C693-45C5-8F71-DCA63251C26E

Q35122057-A47C2668-309E-4E9C-ABF1-2962DC08736E

Q35122057-B40D48AE-059C-4313-A552-38D1C29CC43F

Q35122057-DA76A6FB-A633-4FCE-A233-7E060A2BBD55

Q35122057-E7D18F05-7EA6-45F9-9B9B-6FB9B1A12ACD

P2860

Q35122057-00F5BCC2-924B-4D3B-81E3-7E2BC7500C58

Q35122057-0D976E01-4FFE-456F-AE7A-62DF2F0665D6

Q35122057-1749C226-C368-440A-811A-9A8D9449F00B

Q35122057-19FF0E90-CAC0-43ED-B4A6-F06CDEB8BF48

Q35122057-1B969B3A-ECF1-48C6-86FB-653E44219ABB

Q35122057-1C42091D-F1BA-4352-8276-E3FD3EC0C046

Q35122057-313F0171-9137-480D-9D98-CC15562839C4

Q35122057-3246EED4-3468-4F0B-8A29-55788745F986

Q35122057-3848F8F0-7154-4C64-86E9-5DA365C2981C

Q35122057-525C8BC3-E8E8-4332-B070-AC5B62B8E6D6

P304

Q35122057-91DE0968-DA4A-4A63-BA0E-8788EF220C87

P31

Q35122057-3A48DEF3-F16F-4C60-8231-F51C4279A9C9

P356

Q35122057-9E0D67D9-0B54-43F2-B111-4E079C6C9A10

P407

Q35122057-7418C6A5-E490-488E-8CC5-365D5D496669

P433

Q35122057-14C9759A-2072-4334-BF5A-820F5917B558

P478

Q35122057-911D2868-9C85-4605-A259-817D2665E535

P577

Q35122057-2EE4B7B3-EBC7-4E74-90B9-5BFC46D60E05

P5875

Q35122057-56015154-7D66-4FB7-8EEB-53313AE2F99A

P698

Q35122057-102495C3-2504-452F-ACDA-26F3C8ED54EE

P932

Q35122057-FA63989C-9E8C-4F20-B4A4-D34AED901C97

P356

JOURNAL.PONE.0085705

P1433

P1476

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

@en

P2093

Feifei Song

http://www.w3.org/2001/XMLSchema#string

Guohua Xie

http://www.w3.org/2001/XMLSchema#string

Hailiang Ge

http://www.w3.org/2001/XMLSchema#string

Huizhen Zhang

http://www.w3.org/2001/XMLSchema#string

Lisong Shen

http://www.w3.org/2001/XMLSchema#string

Qinqin Yin

http://www.w3.org/2001/XMLSchema#string

Renfeng Zhang

http://www.w3.org/2001/XMLSchema#string

Shujun Wang

http://www.w3.org/2001/XMLSchema#string

Wei Rao

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Regulation of TSC2 by 14-3-3 binding

5-fluorouracil: mechanisms of action and clinical strategies

14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s)

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

Transformation of mammalian cells by constitutively active MAP kinase kinase

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

[The effects of tumor antigen gene OVA66 on biological characteristics of tumor cells].

Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity.

Tumor antigen targets and tumor immunotherapy.

P304

e85705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0085705

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260842023

http://www.w3.org/2001/XMLSchema#string

P698

24633332

http://www.w3.org/2001/XMLSchema#string

P932

3954546

http://www.w3.org/2001/XMLSchema#string